Related Blog Posts
Neovacs Initiates a Phase II Clinical Trial of TNF Kinoid in Rheumatoid Arthritis Patients Failing TNF Monoclonal Antibody Therapy
6 hours ago ago from story-tour.com
Business Wire, Dec 08, 2009 PARIS Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNF Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNF monoclonal antibody and who test positive for anti-drug antibodies (ADAs). The announcement follows trial clearance by ...
Related contentNew Treatment Eyed for Ewing's Sarcoma
4 hours ago ago from net2dvd
WEDNESDAY, Dec. 23 (HealthDay News) Preliminary research suggests that the anticancer drug figitumumab might be an effective treatment for Ewing's sarcoma, a cancer that affects the areas in and near the bone, mainly in teenage boys. The drug must undergo two more phases of testing, however, according to a report published in the Dec. 23 online edition of The Lancet Oncology . In the first phase of research, ...
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
